Download the free
Alpha-1 antitrypsin deficiency
Sano worked with an industry-leading Sponsor to rapidly deliver genetically qualified volunteers for a precision medicine clinical study in Alpha-1 antitrypsin deficiency.
The primary genetic variant desired by the client is only present in 1 in 3,000 Europeans and is even rarer in non-Europeans.
65 genetically qualified referrals
90% of the referral target delivered within 1 month of the agreed 4 month recruitment period